Gene Symbol | Gene ID | Gene Info |
---|---|---|
DPRX
|
ENSG00000204595.1 | divergent-paired related homeobox |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_73483972_73484180 | 0.54 |
TRPM3 |
transient receptor potential cation channel, subfamily M, member 3 |
102 |
0.98 |
chr6_86163029_86163180 | 0.52 |
NT5E |
5'-nucleotidase, ecto (CD73) |
3277 |
0.35 |
chr8_49831086_49831370 | 0.48 |
SNAI2 |
snail family zinc finger 2 |
2760 |
0.41 |
chr19_44860491_44860902 | 0.47 |
ZNF112 |
zinc finger protein 112 |
130 |
0.96 |
chr12_47358473_47358699 | 0.46 |
PCED1B |
PC-esterase domain containing 1B |
114800 |
0.06 |
chr3_66139685_66140118 | 0.45 |
SLC25A26 |
solute carrier family 25 (S-adenosylmethionine carrier), member 26 |
20616 |
0.25 |
chr1_163040363_163040678 | 0.42 |
RGS4 |
regulator of G-protein signaling 4 |
1314 |
0.56 |
chr1_170632786_170633084 | 0.41 |
PRRX1 |
paired related homeobox 1 |
112 |
0.98 |
chr10_97049818_97050125 | 0.41 |
PDLIM1 |
PDZ and LIM domain 1 |
810 |
0.7 |
chrX_45634801_45635003 | 0.41 |
ENSG00000207725 |
. |
28372 |
0.2 |
chr9_13278507_13279169 | 0.39 |
RP11-272P10.2 |
|
348 |
0.67 |
chr5_54456050_54456451 | 0.39 |
GPX8 |
glutathione peroxidase 8 (putative) |
252 |
0.86 |
chr4_41157110_41157449 | 0.39 |
ENSG00000207198 |
. |
41320 |
0.14 |
chr8_55294582_55295235 | 0.38 |
ENSG00000244107 |
. |
38120 |
0.17 |
chr3_100711062_100711329 | 0.38 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
1102 |
0.61 |
chr22_31198410_31198813 | 0.38 |
OSBP2 |
oxysterol binding protein 2 |
462 |
0.84 |
chr6_72178498_72178870 | 0.37 |
ENSG00000207827 |
. |
65360 |
0.11 |
chr12_12972772_12973017 | 0.37 |
DDX47 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 |
6600 |
0.18 |
chr7_90012947_90013805 | 0.36 |
CLDN12 |
claudin 12 |
341 |
0.9 |
chr13_73715664_73715973 | 0.36 |
ENSG00000265959 |
. |
16871 |
0.19 |
chr11_66083364_66083632 | 0.35 |
CD248 |
CD248 molecule, endosialin |
1017 |
0.24 |
chr15_59663421_59663716 | 0.34 |
FAM81A |
family with sequence similarity 81, member A |
1324 |
0.28 |
chr3_150088154_150088521 | 0.34 |
TSC22D2 |
TSC22 domain family, member 2 |
37785 |
0.2 |
chr4_148693225_148693748 | 0.33 |
ENSG00000264274 |
. |
10260 |
0.18 |
chr13_40175117_40175459 | 0.33 |
LHFP |
lipoma HMGIC fusion partner |
2020 |
0.37 |
chr9_14251628_14251810 | 0.33 |
NFIB |
nuclear factor I/B |
56293 |
0.15 |
chr5_35851300_35851523 | 0.33 |
IL7R |
interleukin 7 receptor |
1386 |
0.45 |
chr15_23931247_23932124 | 0.33 |
NDN |
necdin, melanoma antigen (MAGE) family member |
765 |
0.7 |
chr2_134325508_134325697 | 0.33 |
NCKAP5 |
NCK-associated protein 5 |
429 |
0.88 |
chr3_173302379_173302636 | 0.33 |
NLGN1 |
neuroligin 1 |
162 |
0.98 |
chr6_116833589_116833880 | 0.33 |
TRAPPC3L |
trafficking protein particle complex 3-like |
228 |
0.83 |
chr15_96868857_96869008 | 0.33 |
NR2F2 |
nuclear receptor subfamily 2, group F, member 2 |
235 |
0.88 |
chr6_26424520_26424724 | 0.32 |
BTN2A3P |
butyrophilin, subfamily 2, member A3, pseudogene |
2275 |
0.18 |
chr1_82266791_82267081 | 0.32 |
LPHN2 |
latrophilin 2 |
854 |
0.76 |
chr6_5498160_5498518 | 0.32 |
RP1-232P20.1 |
|
40031 |
0.2 |
chr12_66122461_66123138 | 0.32 |
HMGA2 |
high mobility group AT-hook 2 |
95112 |
0.08 |
chr3_128207705_128209147 | 0.32 |
RP11-475N22.4 |
|
326 |
0.79 |
chr8_57360709_57360896 | 0.31 |
PENK |
proenkephalin |
1509 |
0.41 |
chr14_69015254_69015531 | 0.31 |
CTD-2325P2.4 |
|
79770 |
0.1 |
chr10_4284322_4284712 | 0.31 |
ENSG00000207124 |
. |
272627 |
0.02 |
chr2_217180593_217180957 | 0.31 |
AC069155.1 |
|
12727 |
0.18 |
chr3_192126971_192127690 | 0.31 |
FGF12 |
fibroblast growth factor 12 |
492 |
0.87 |
chr1_170630999_170631537 | 0.30 |
PRRX1 |
paired related homeobox 1 |
1007 |
0.68 |
chrX_135231057_135231247 | 0.30 |
FHL1 |
four and a half LIM domains 1 |
415 |
0.86 |
chr10_60275835_60276146 | 0.30 |
BICC1 |
bicaudal C homolog 1 (Drosophila) |
3090 |
0.38 |
chr1_7812599_7812750 | 0.30 |
CAMTA1 |
calmodulin binding transcription activator 1 |
7653 |
0.17 |
chr1_61668583_61669016 | 0.30 |
RP4-802A10.1 |
|
78394 |
0.11 |
chr15_39874864_39875069 | 0.30 |
THBS1 |
thrombospondin 1 |
1672 |
0.37 |
chr10_92680755_92680938 | 0.30 |
ANKRD1 |
ankyrin repeat domain 1 (cardiac muscle) |
187 |
0.93 |
chr2_237654651_237654995 | 0.29 |
ACKR3 |
atypical chemokine receptor 3 |
176539 |
0.03 |
chr5_125475529_125475786 | 0.29 |
ENSG00000265637 |
. |
56871 |
0.17 |
chr4_41215270_41215769 | 0.29 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
956 |
0.59 |
chr7_116141197_116141631 | 0.29 |
CAV2 |
caveolin 2 |
1580 |
0.29 |
chr19_48101898_48102049 | 0.29 |
GLTSCR1 |
glioma tumor suppressor candidate region gene 1 |
9480 |
0.14 |
chr4_154125621_154125824 | 0.29 |
TRIM2 |
tripartite motif containing 2 |
104 |
0.98 |
chr13_30276703_30277107 | 0.29 |
SLC7A1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
107080 |
0.07 |
chr7_134464463_134465343 | 0.28 |
CALD1 |
caldesmon 1 |
474 |
0.89 |
chr20_14317138_14317687 | 0.28 |
FLRT3 |
fibronectin leucine rich transmembrane protein 3 |
842 |
0.69 |
chr7_82071322_82071473 | 0.28 |
CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
1634 |
0.55 |
chr6_128812548_128813040 | 0.28 |
RP1-86D1.5 |
|
8878 |
0.17 |
chr13_102572043_102572458 | 0.27 |
FGF14 |
fibroblast growth factor 14 |
3255 |
0.32 |
chr1_16085392_16086186 | 0.27 |
FBLIM1 |
filamin binding LIM protein 1 |
497 |
0.68 |
chr13_38171648_38172094 | 0.27 |
POSTN |
periostin, osteoblast specific factor |
992 |
0.71 |
chr7_28944342_28944522 | 0.27 |
CTB-113D17.1 |
|
75151 |
0.1 |
chr10_30842846_30843212 | 0.27 |
ENSG00000239744 |
. |
1804 |
0.44 |
chr17_12877545_12877942 | 0.27 |
ENSG00000266152 |
. |
1601 |
0.34 |
chr17_39205284_39205523 | 0.26 |
KRTAP2-1 |
keratin associated protein 2-1 |
1835 |
0.12 |
chr18_65983753_65984295 | 0.26 |
TMX3 |
thioredoxin-related transmembrane protein 3 |
398270 |
0.01 |
chr3_87040086_87040946 | 0.26 |
VGLL3 |
vestigial like 3 (Drosophila) |
247 |
0.96 |
chr10_3929254_3929732 | 0.26 |
KLF6 |
Kruppel-like factor 6 |
102020 |
0.08 |
chrX_114796559_114796881 | 0.26 |
RP1-93I3.1 |
|
314 |
0.83 |
chr3_100730225_100730376 | 0.26 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
17941 |
0.25 |
chr10_112258642_112259418 | 0.26 |
DUSP5 |
dual specificity phosphatase 5 |
1434 |
0.41 |
chr11_35585007_35585160 | 0.26 |
PAMR1 |
peptidase domain containing associated with muscle regeneration 1 |
33235 |
0.18 |
chr4_55098050_55098472 | 0.26 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
1772 |
0.47 |
chr4_81230543_81230858 | 0.26 |
C4orf22 |
chromosome 4 open reading frame 22 |
26174 |
0.21 |
chr11_69458516_69459047 | 0.25 |
CCND1 |
cyclin D1 |
2807 |
0.29 |
chr4_126243331_126243824 | 0.25 |
FAT4 |
FAT atypical cadherin 4 |
6023 |
0.3 |
chr15_89914451_89914936 | 0.25 |
ENSG00000207819 |
. |
3445 |
0.23 |
chr15_48937037_48938293 | 0.25 |
FBN1 |
fibrillin 1 |
253 |
0.95 |
chr1_67446927_67447083 | 0.25 |
MIER1 |
mesoderm induction early response 1, transcriptional regulator |
51079 |
0.12 |
chr21_30673835_30674113 | 0.25 |
BACH1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
851 |
0.62 |
chr15_96878987_96879612 | 0.25 |
ENSG00000222651 |
. |
2809 |
0.21 |
chr16_4162280_4162503 | 0.25 |
ADCY9 |
adenylate cyclase 9 |
1636 |
0.44 |
chr2_206540536_206540687 | 0.25 |
NRP2 |
neuropilin 2 |
6613 |
0.3 |
chr10_116444886_116445037 | 0.25 |
ABLIM1 |
actin binding LIM protein 1 |
547 |
0.83 |
chr1_215181525_215181703 | 0.25 |
KCNK2 |
potassium channel, subfamily K, member 2 |
2416 |
0.46 |
chr12_88972313_88972545 | 0.25 |
KITLG |
KIT ligand |
1809 |
0.39 |
chr12_91570586_91570804 | 0.25 |
DCN |
decorin |
1634 |
0.5 |
chr8_97172057_97172969 | 0.25 |
GDF6 |
growth differentiation factor 6 |
507 |
0.84 |
chr17_77019963_77021139 | 0.25 |
C1QTNF1 |
C1q and tumor necrosis factor related protein 1 |
208 |
0.91 |
chr2_213641909_213642154 | 0.24 |
ENSG00000221388 |
. |
13632 |
0.3 |
chr1_215697066_215697229 | 0.24 |
KCTD3 |
potassium channel tetramerization domain containing 3 |
43588 |
0.2 |
chr22_39801646_39801840 | 0.24 |
TAB1 |
TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
5954 |
0.16 |
chr3_114477226_114477377 | 0.24 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
486 |
0.86 |
chr9_4838369_4838520 | 0.24 |
RCL1 |
RNA terminal phosphate cyclase-like 1 |
1074 |
0.46 |
chr6_84418004_84418417 | 0.24 |
SNAP91 |
synaptosomal-associated protein, 91kDa |
77 |
0.99 |
chr10_118764443_118765166 | 0.23 |
KIAA1598 |
KIAA1598 |
72 |
0.98 |
chr7_18548938_18549201 | 0.23 |
HDAC9 |
histone deacetylase 9 |
133 |
0.98 |
chr5_59040900_59041158 | 0.23 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
23433 |
0.24 |
chr20_8627018_8627192 | 0.23 |
ENSG00000222298 |
. |
36218 |
0.18 |
chr4_4494063_4494282 | 0.23 |
STX18-IT1 |
STX18 intronic transcript 1 (non-protein coding) |
10745 |
0.21 |
chr2_230131761_230131912 | 0.23 |
PID1 |
phosphotyrosine interaction domain containing 1 |
4145 |
0.31 |
chr12_72667295_72667865 | 0.23 |
TRHDE |
thyrotropin-releasing hormone degrading enzyme |
317 |
0.85 |
chr9_131684300_131684733 | 0.23 |
PHYHD1 |
phytanoyl-CoA dioxygenase domain containing 1 |
46 |
0.96 |
chr6_84418438_84418730 | 0.23 |
SNAP91 |
synaptosomal-associated protein, 91kDa |
147 |
0.98 |
chr8_29664962_29665155 | 0.23 |
ENSG00000221003 |
. |
121063 |
0.06 |
chr16_86619409_86619937 | 0.23 |
FOXL1 |
forkhead box L1 |
7558 |
0.18 |
chr11_108542944_108543195 | 0.23 |
DDX10 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 |
7220 |
0.29 |
chr7_94536809_94537187 | 0.23 |
PPP1R9A |
protein phosphatase 1, regulatory subunit 9A |
11 |
0.99 |
chr9_21558261_21558438 | 0.23 |
MIR31HG |
MIR31 host gene (non-protein coding) |
1319 |
0.44 |
chrX_19688369_19688923 | 0.23 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
166 |
0.97 |
chr1_245951382_245951568 | 0.23 |
RP11-522M21.3 |
|
111695 |
0.07 |
chr2_199236865_199237052 | 0.22 |
ENSG00000252511 |
. |
194495 |
0.03 |
chr17_762649_762818 | 0.22 |
NXN |
nucleoredoxin |
4604 |
0.18 |
chr1_119543090_119543475 | 0.22 |
TBX15 |
T-box 15 |
11103 |
0.25 |
chr1_98499845_98500395 | 0.22 |
ENSG00000225206 |
. |
10787 |
0.31 |
chr4_128703513_128704516 | 0.22 |
HSPA4L |
heat shock 70kDa protein 4-like |
537 |
0.81 |
chr2_218807657_218808117 | 0.22 |
TNS1 |
tensin 1 |
906 |
0.64 |
chr17_17851472_17851637 | 0.22 |
TOM1L2 |
target of myb1-like 2 (chicken) |
24157 |
0.14 |
chr16_640288_641115 | 0.22 |
RAB40C |
RAB40C, member RAS oncogene family |
369 |
0.68 |
chr18_9416679_9416911 | 0.22 |
RALBP1 |
ralA binding protein 1 |
58212 |
0.1 |
chr13_37492943_37493377 | 0.22 |
SMAD9 |
SMAD family member 9 |
1215 |
0.52 |
chr1_57111479_57111630 | 0.22 |
PRKAA2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
559 |
0.84 |
chr10_23092690_23092841 | 0.22 |
ENSG00000206842 |
. |
16443 |
0.26 |
chr3_62360137_62360326 | 0.22 |
FEZF2 |
FEZ family zinc finger 2 |
232 |
0.94 |
chr13_45147711_45147927 | 0.22 |
TSC22D1 |
TSC22 domain family, member 1 |
2573 |
0.38 |
chr15_99664067_99664316 | 0.22 |
RP11-6O2.4 |
|
7820 |
0.14 |
chr21_31599857_31600016 | 0.21 |
CLDN8 |
claudin 8 |
11545 |
0.17 |
chr8_87052179_87052395 | 0.21 |
PSKH2 |
protein serine kinase H2 |
29639 |
0.19 |
chr1_231964431_231964582 | 0.21 |
DISC1-IT1 |
DISC1 intronic transcript 1 (non-protein coding) |
97074 |
0.08 |
chr2_236514053_236514361 | 0.21 |
ENSG00000221704 |
. |
33632 |
0.2 |
chr6_42283591_42283839 | 0.21 |
ENSG00000221252 |
. |
96419 |
0.06 |
chr21_28335011_28335184 | 0.21 |
ADAMTS5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
3735 |
0.27 |
chr7_92264053_92264321 | 0.21 |
FAM133B |
family with sequence similarity 133, member B |
44479 |
0.15 |
chr14_101034010_101035263 | 0.21 |
BEGAIN |
brain-enriched guanylate kinase-associated |
192 |
0.93 |
chr5_107040810_107041069 | 0.21 |
ENSG00000239708 |
. |
29828 |
0.21 |
chr17_60868253_60868692 | 0.21 |
MARCH10 |
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase |
15529 |
0.23 |
chr10_114552786_114553214 | 0.21 |
RP11-57H14.4 |
|
30249 |
0.21 |
chr6_85484117_85484534 | 0.21 |
TBX18 |
T-box 18 |
10088 |
0.3 |
chr7_84440948_84441099 | 0.21 |
ENSG00000265050 |
. |
145699 |
0.05 |
chr1_212841074_212841261 | 0.21 |
ENSG00000207491 |
. |
24439 |
0.13 |
chr5_71403169_71403320 | 0.21 |
MAP1B |
microtubule-associated protein 1B |
69 |
0.98 |
chr4_138045655_138046009 | 0.21 |
ENSG00000222526 |
. |
103450 |
0.09 |
chr5_111165128_111165279 | 0.21 |
NREP |
neuronal regeneration related protein |
71288 |
0.1 |
chr12_101188772_101189038 | 0.21 |
ANO4 |
anoctamin 4 |
169 |
0.97 |
chr12_42876039_42876190 | 0.21 |
PRICKLE1 |
prickle homolog 1 (Drosophila) |
760 |
0.61 |
chr6_3844247_3844398 | 0.21 |
FAM50B |
family with sequence similarity 50, member B |
5298 |
0.22 |
chr5_167000298_167000463 | 0.21 |
CTB-78F1.1 |
|
87106 |
0.09 |
chr1_161931679_161931926 | 0.20 |
OLFML2B |
olfactomedin-like 2B |
23220 |
0.22 |
chr16_54209442_54209593 | 0.20 |
RP11-324D17.1 |
HCG2045435; Uncharacterized protein |
71360 |
0.11 |
chr16_54321004_54321411 | 0.20 |
IRX3 |
iroquois homeobox 3 |
532 |
0.83 |
chr3_25472946_25473178 | 0.20 |
RARB |
retinoic acid receptor, beta |
3260 |
0.35 |
chr6_10415043_10415268 | 0.20 |
TFAP2A |
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
63 |
0.82 |
chr7_51101841_51102176 | 0.20 |
RP4-724E13.2 |
|
16848 |
0.28 |
chr4_169643911_169644062 | 0.20 |
PALLD |
palladin, cytoskeletal associated protein |
10676 |
0.22 |
chr9_79450389_79450574 | 0.20 |
PRUNE2 |
prune homolog 2 (Drosophila) |
70520 |
0.11 |
chr6_72892116_72892352 | 0.20 |
RIMS1 |
regulating synaptic membrane exocytosis 1 |
221 |
0.96 |
chr5_123036641_123036976 | 0.20 |
CSNK1G3 |
casein kinase 1, gamma 3 |
112689 |
0.07 |
chr5_77584190_77584360 | 0.20 |
AP3B1 |
adaptor-related protein complex 3, beta 1 subunit |
6241 |
0.22 |
chr1_23066485_23066803 | 0.20 |
ENSG00000216157 |
. |
8760 |
0.17 |
chr1_185373783_185374254 | 0.20 |
ENSG00000252407 |
. |
29358 |
0.21 |
chr3_58810226_58810377 | 0.20 |
RP11-147N17.1 |
|
104 |
0.98 |
chr10_69866394_69866619 | 0.20 |
MYPN |
myopalladin |
594 |
0.76 |
chr6_1614659_1614953 | 0.20 |
FOXC1 |
forkhead box C1 |
4125 |
0.35 |
chr16_72570565_72570716 | 0.20 |
ENSG00000221286 |
. |
42896 |
0.18 |
chr2_239792608_239792759 | 0.20 |
TWIST2 |
twist family bHLH transcription factor 2 |
36010 |
0.18 |
chr8_65488422_65488732 | 0.20 |
RP11-21C4.1 |
|
1243 |
0.52 |
chr6_151648743_151648894 | 0.20 |
AKAP12 |
A kinase (PRKA) anchor protein 12 |
1995 |
0.23 |
chr10_17391082_17391289 | 0.20 |
ST8SIA6 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 |
22077 |
0.18 |
chr7_127911991_127912224 | 0.20 |
ENSG00000221429 |
. |
17950 |
0.16 |
chr20_10720180_10720390 | 0.20 |
JAG1 |
jagged 1 |
65591 |
0.13 |
chr2_227661871_227662069 | 0.20 |
IRS1 |
insulin receptor substrate 1 |
2505 |
0.3 |
chr4_134068181_134068851 | 0.20 |
PCDH10 |
protocadherin 10 |
1954 |
0.52 |
chr19_1361236_1361464 | 0.19 |
MUM1 |
melanoma associated antigen (mutated) 1 |
4987 |
0.1 |
chr2_172388580_172388749 | 0.19 |
CYBRD1 |
cytochrome b reductase 1 |
9075 |
0.25 |
chr3_190812364_190812515 | 0.19 |
OSTN |
osteocrin |
104591 |
0.07 |
chr22_36841557_36841862 | 0.19 |
ENSG00000252225 |
. |
4694 |
0.17 |
chr12_91503113_91503264 | 0.19 |
LUM |
lumican |
2420 |
0.34 |
chr3_159898355_159898715 | 0.19 |
IL12A-AS1 |
IL12A antisense RNA 1 |
26344 |
0.17 |
chr5_127981136_127981287 | 0.19 |
FBN2 |
fibrillin 2 |
13667 |
0.23 |
chr1_172558158_172558450 | 0.19 |
ENSG00000251943 |
. |
24370 |
0.2 |
chr10_114819686_114819837 | 0.19 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
83918 |
0.1 |
chr5_111890138_111890295 | 0.19 |
EPB41L4A-AS2 |
EPB41L4A antisense RNA 2 (head to head) |
134936 |
0.05 |
chr3_30852868_30853019 | 0.19 |
GADL1 |
glutamate decarboxylase-like 1 |
83210 |
0.1 |
chr6_56405735_56406219 | 0.19 |
DST |
dystonin |
67189 |
0.13 |
chr20_10562988_10563139 | 0.19 |
JAG1 |
jagged 1 |
80091 |
0.1 |
chr14_52122113_52122363 | 0.19 |
FRMD6 |
FERM domain containing 6 |
3540 |
0.25 |
chr12_41091641_41091792 | 0.19 |
CNTN1 |
contactin 1 |
5362 |
0.33 |
chr5_78365996_78366206 | 0.19 |
BHMT2 |
betaine--homocysteine S-methyltransferase 2 |
511 |
0.53 |
chr10_98750971_98751122 | 0.19 |
RP11-175O19.4 |
|
1161 |
0.5 |
chr3_101547890_101548066 | 0.19 |
NFKBIZ |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
1141 |
0.47 |
chr12_109227226_109227475 | 0.19 |
ENSG00000207622 |
. |
3432 |
0.19 |
chr4_153272243_153272573 | 0.19 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
1715 |
0.41 |
chr9_34651822_34652525 | 0.19 |
IL11RA |
interleukin 11 receptor, alpha |
16 |
0.94 |
chr1_162665785_162665936 | 0.19 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
63600 |
0.1 |
chr12_32655077_32655322 | 0.19 |
FGD4 |
FYVE, RhoGEF and PH domain containing 4 |
48 |
0.98 |
chr20_22756193_22756438 | 0.19 |
ENSG00000265151 |
. |
42376 |
0.2 |
chr10_74878153_74878313 | 0.19 |
RP11-152N13.16 |
|
6930 |
0.1 |
chr9_22008460_22008654 | 0.19 |
CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
395 |
0.82 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.4 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.4 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.3 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.3 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 1.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) auditory behavior(GO:0031223) |
0.1 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.2 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.2 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.2 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.1 | 0.2 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.1 | 0.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.0 | 0.1 | GO:0030540 | female genitalia development(GO:0030540) |
0.0 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0051938 | L-glutamate import(GO:0051938) |
0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.4 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.0 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.0 | 0.1 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.2 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.0 | GO:0060197 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:0034653 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.0 | 0.3 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.1 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.2 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.0 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.1 | GO:1904748 | regulation of apoptotic process involved in morphogenesis(GO:1902337) regulation of apoptotic process involved in development(GO:1904748) |
0.0 | 0.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.5 | GO:1901800 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.4 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.0 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.0 | GO:0051284 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.0 | 0.2 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.1 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.0 | 0.0 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.0 | GO:0060596 | mammary placode formation(GO:0060596) |
0.0 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0060435 | bronchiole development(GO:0060435) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.0 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.0 | GO:0032353 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.0 | 0.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.0 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) regulation of follicle-stimulating hormone secretion(GO:0046880) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.1 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.0 | 0.2 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 1.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0042596 | behavioral fear response(GO:0001662) fear response(GO:0042596) |
0.0 | 0.0 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.0 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.1 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.0 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.0 | 0.1 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.2 | GO:2000181 | negative regulation of blood vessel morphogenesis(GO:2000181) |
0.0 | 0.3 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.0 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.0 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0010665 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.0 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.0 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:0048143 | astrocyte activation(GO:0048143) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.0 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.3 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.3 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.2 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.0 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.3 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 1.3 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.7 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.8 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 1.3 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 2.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.9 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 1.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.4 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.2 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.0 | 0.0 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.0 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 2.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.3 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.0 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.0 | 0.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |